New drug trial targets stubborn hormonal high blood pressure
NCT ID NCT07470983
Summary
This study is testing an investigational drug called HRS-1780 to see if it can safely lower blood pressure in adults with primary aldosteronism, a condition where the adrenal glands produce too much of a hormone that raises blood pressure. About 60 participants will be randomly assigned to receive either the real drug or a placebo (a dummy pill) for comparison. The main goal is to measure changes in blood pressure and key blood minerals like potassium to see if the drug is effective and safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY ALDOSTERONISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, 400016, China
Contact
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, 450052, China
Contact
Conditions
Explore the condition pages connected to this study.